These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 8492953)

  • 1. Olfactory testing differentiates between progressive supranuclear palsy and idiopathic Parkinson's disease.
    Doty RL; Golbe LI; McKeown DA; Stern MB; Lehrach CM; Crawford D
    Neurology; 1993 May; 43(5):962-5. PubMed ID: 8492953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Card-type Odor Identification Test for Japanese Patients with Parkinson's Disease and Related Disorders.
    Watanabe Y; Suzuki K; Miyamoto T; Miyamoto M; Numao A; Fujita H; Uchiyama T; Kadowaki T; Matsubara T; Hirata K
    Intern Med; 2017 Nov; 56(21):2871-2878. PubMed ID: 28943542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The odor stick identification test for Japanese differentiates Parkinson's disease from multiple system atrophy and progressive supra nuclear palsy.
    Suzuki M; Hashimoto M; Yoshioka M; Murakami M; Kawasaki K; Urashima M
    BMC Neurol; 2011 Dec; 11():157. PubMed ID: 22192419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Olfaction in Neuropathologically Defined Progressive Supranuclear Palsy.
    Shill HA; Zhang N; Driver-Dunckley E; Mehta S; Adler CH; Beach TG
    Mov Disord; 2021 Jul; 36(7):1700-1704. PubMed ID: 33755262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computerized posturography analysis of progressive supranuclear palsy: a case-control comparison with Parkinson's disease and healthy controls.
    Ondo W; Warrior D; Overby A; Calmes J; Hendersen N; Olson S; Jankovic J
    Arch Neurol; 2000 Oct; 57(10):1464-9. PubMed ID: 11030799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Force control deficits in individuals with Parkinson's disease, multiple systems atrophy, and progressive supranuclear palsy.
    Neely KA; Planetta PJ; Prodoehl J; Corcos DM; Comella CL; Goetz CG; Shannon KL; Vaillancourt DE
    PLoS One; 2013; 8(3):e58403. PubMed ID: 23505500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiating progressive supranuclear palsy from Parkinson's disease by MRI-based dynamic cerebrospinal fluid flow.
    Fukui Y; Hishikawa N; Sato K; Yunoki T; Kono S; Matsuzono K; Nakano Y; Ohta Y; Yamashita T; Deguchi K; Abe K
    J Neurol Sci; 2015 Oct; 357(1-2):178-82. PubMed ID: 26227830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acoustical analysis of speech in progressive supranuclear palsy.
    Skodda S; Visser W; Schlegel U
    J Voice; 2011 Nov; 25(6):725-31. PubMed ID: 20457507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative evaluation of oculomotor disturbances in progressive supranuclear palsy.
    Pagonabarraga J; Horta-Barba A; Busteed L; Bejr-Kasem H; Illán-Gala I; Aracil-Bolaños I; Marín-Lahoz J; Pascual-Sedano B; Pérez J; Campolongo A; Izquierdo C; Martinez-Horta S; Sampedro F; Kulisevsky J
    Parkinsonism Relat Disord; 2021 Apr; 85():63-68. PubMed ID: 33744691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Machine learning on brain MRI data for differential diagnosis of Parkinson's disease and Progressive Supranuclear Palsy.
    Salvatore C; Cerasa A; Castiglioni I; Gallivanone F; Augimeri A; Lopez M; Arabia G; Morelli M; Gilardi MC; Quattrone A
    J Neurosci Methods; 2014 Jan; 222():230-7. PubMed ID: 24286700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sniffing the diagnosis: Olfactory testing in neurodegenerative parkinsonism.
    Krismer F; Pinter B; Mueller C; Mahlknecht P; Nocker M; Reiter E; Djamshidian-Tehrani A; Boesch SM; Wenning GK; Scherfler C; Poewe W; Seppi K
    Parkinsonism Relat Disord; 2017 Feb; 35():36-41. PubMed ID: 27890451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediagnostic motor and non-motor symptoms in progressive supranuclear palsy: The step-back PSP study.
    Painous C; Martí MJ; Simonet C; Garrido A; Valldeoriola F; Muñoz E; Cámara A; Compta Y
    Parkinsonism Relat Disord; 2020 May; 74():67-73. PubMed ID: 32536421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Olfactory dysfunction in parkinsonism: a general deficit unrelated to neurologic signs, disease stage, or disease duration.
    Doty RL; Deems DA; Stellar S
    Neurology; 1988 Aug; 38(8):1237-44. PubMed ID: 3399075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct patterns of brain activity in progressive supranuclear palsy and Parkinson's disease.
    Burciu RG; Ofori E; Shukla P; Planetta PJ; Snyder AF; Li H; Hass CJ; Okun MS; McFarland NR; Vaillancourt DE
    Mov Disord; 2015 Aug; 30(9):1248-58. PubMed ID: 26148135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apparent diffusion coefficient of the superior cerebellar peduncle differentiates progressive supranuclear palsy from Parkinson's disease.
    Nicoletti G; Tonon C; Lodi R; Condino F; Manners D; Malucelli E; Morelli M; Novellino F; Paglionico S; Lanza P; Messina D; Barone P; Morgante L; Zappia M; Barbiroli B; Quattrone A
    Mov Disord; 2008 Dec; 23(16):2370-6. PubMed ID: 18816803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ratio of square wave jerk rates to blink rates distinguishes progressive supranuclear palsy from Parkinson disease.
    Altiparmak UE; Eggenberger E; Coleman A; Condon K
    J Neuroophthalmol; 2006 Dec; 26(4):257-9. PubMed ID: 17204917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combining quantitative susceptibility mapping to the morphometric index in differentiating between progressive supranuclear palsy and Parkinson's disease.
    Azuma M; Hirai T; Nakaura T; Kitajima M; Yamashita S; Hashimoto M; Yamada K; Uetani H; Yamashita Y; Wang Y
    J Neurol Sci; 2019 Nov; 406():116443. PubMed ID: 31634718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salivary alpha-synuclein in the diagnosis of Parkinson's disease and Progressive Supranuclear Palsy.
    Vivacqua G; Suppa A; Mancinelli R; Belvisi D; Fabbrini A; Costanzo M; Formica A; Onori P; Fabbrini G; Berardelli A
    Parkinsonism Relat Disord; 2019 Jun; 63():143-148. PubMed ID: 30796010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "Applause sign" helps to discriminate PSP from FTD and PD.
    Dubois B; Slachevsky A; Pillon B; Beato R; Villalponda JM; Litvan I
    Neurology; 2005 Jun; 64(12):2132-3. PubMed ID: 15985587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PTPRC Expression in Blood is Downregulated in Parkinson's and Progressive Supranuclear Palsy Disorders.
    Bottero V; Santiago JA; Potashkin JA
    J Parkinsons Dis; 2018; 8(4):529-537. PubMed ID: 30248063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.